Fecal Elastase‑1 Test in UAE | 1300 AED | DHA‑Licensed

Executive Summary & Core Metrics

Trust Promise & Service Highlights

Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing (Cert: INT/EGQ/2509DA/3139).
Premium Logistics: At-home stool sample collection with ISO‑certified cold‑chain transport; collection available daily 8 AM – 11 PM.
Clinical Guidance: Complimentary telephonic post‑test clinical correlation from our DHA‑licensed expert panel.
Insurance: Direct billing eligibility check via WhatsApp +971 54 548 8731. Seamless pre‑approval processing.

Test Overview & Methodology

The fecal elastase‑1 test directly measures pancreatic exocrine output using a highly specific enzyme immunoassay (ELISA). It is the preferred non‑invasive marker for ruling in/out exocrine pancreatic insufficiency (EPI) in patients with chronic pancreatitis, cystic fibrosis, or unexplained steatorrhea. Because elastase‑1 remains stable during intestinal transit, a single stool sample—refrigerated or frozen—delivers reliable, quantitative insight. Normal values above 200 µg/g stool effectively exclude severe insufficiency, while levels <100 µg/g confirm EPI with 93% sensitivity.

Feature	Our ISO‑Certified Test	Closest Alternative (Generic Lab)
Precision / Methodology	ELISA (enzyme‑linked immunosorbent assay) with monoclonal antibodies – intra‑assay CV <5%	Polyclonal ELISA; CV often >10%
Turnaround Time	Sample collected Tue/Fri by 6 PM → Report next day before 4 PM	48‑72 h; batch processing delay
Supply Chain	ISO 9001:2015 cold chain; real‑time temperature log	Standard cool pack; no chain‑of‑custody audit

Physician Insight & Safety Protocols

“Fecal elastase‑1 is a reliable, non‑invasive marker for exocrine pancreatic insufficiency. However, clinicians must consider clinical context and possible confounders such as small intestinal bacterial overgrowth or prior pancreatic surgery. I guide patients to interpret results holistically, integrating their unique history before initiating therapy.”

— Dr. Ajay Singh, General Practitioner, DHA License 36234132

Medication Advisory

Do not discontinue prescribed medication (e.g., pancreatic enzymes, insulin) without consulting your doctor. This test guides therapy; it does not replace clinical judgement.

Exclusion Criteria & ER Red Flags

Severe acute abdominal pain with guarding or rebound tenderness → visit Emergency Room immediately.
Frank hematochezia (obvious blood in stool) or melena – collect sample after stabilisation.
Recent major pancreatic surgery (<6 weeks) – transient false‑low results.
Uncontrolled diabetes with acute metabolic decompensation.
Children under 6 months – elastase reference ranges differ; contact our paediatric specialist.

Patient FAQ & Clinical Guidance

1. How accurate is the fecal elastase‑1 test for pancreatic insufficiency?

Fecal elastase‑1 measurement by ELISA provides a non‑invasive, quantitative assessment of pancreatic exocrine function with 93% sensitivity and 95% specificity. Our ISO‑accredited protocol eliminates pre‑analytical variability, ensuring that values below 100 µg/g stool are definitive for exocrine pancreatic insufficiency (EPI) in adults, while levels between 100‑200 µg/g warrant further evaluation. Clinical Impact: This result directly guides pancreatic enzyme replacement therapy dosing.

2. Do I need to stop any medications before collecting the stool sample?

No special preparation or medication suspension is required for the fecal elastase‑1 test because elastase‑1 is not affected by oral enzyme supplements. If you are taking pancreatic enzyme replacement therapy (e.g., Creon), continue as prescribed; the result will reflect your true residual function. Important: Never stop insulin or diabetes medications without a physician’s order.

3. How quickly will I receive my results and what do I do next?

Your fecal elastase‑1 report is delivered the next business day after sample arrival, with a comprehensive interpretation guide and direct access to our clinical team. A value <100 µg/g typically triggers a gastroenterology consult and possible imaging; we schedule a tele‑guidance session within 24 h. Next step: Contact your DHA‑licensed specialist on receipt to integrate results with your health plan.

UAE Regulatory & Data Privacy Adherence

This test is performed in full compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All patient data is encrypted, access‑controlled, and processed within Dubai Healthcare City under DHA‑supervised infrastructure. Clinical safety and informed consent follow Federal Decree-Law No. 4 of 2016 on Medical Liability. Your information remains strictly confidential and is used only for diagnostic purposes and mandatory health reporting.

Clinical & Logistical Metadata

Test Name	Fecal Elastase‑1 (Pancreatic Elastase 1)
Price (AED)	1,300
Turnaround Time	Next business day (sample collected Tue/Fri by 6 PM, report before 4 PM next day)
Sample Type / Matrix	Stool (minimum 5 g refrigerated or frozen)
Methodology Used	Enzyme‑Linked Immunosorbent Assay (ELISA) – monoclonal antibodies
ICD-10-CM Code	K86.9 (Unspecified disease of pancreas), K86.1 (Other chronic pancreatitis)
LOINC Code	19123-9 (Elastase 1 [Mass/volume] in Stool)
DHA Facility License & Laboratory Address	License: 1143 \| Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE (DNA Labs UAE)